Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early Atherosclerosis
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Cell Metabolism
- Vol. 8 (6) , 492-501
- https://doi.org/10.1016/j.cmet.2008.09.005
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-κB1 and Attenuates Macrophage ActivationJournal of Biological Chemistry, 2008
- Cyclooxygenase products and atherosclerosisDrug Discovery Today: Therapeutic Strategies, 2008
- Loss of Akt1 Leads to Severe Atherosclerosis and Occlusive Coronary Artery DiseaseCell Metabolism, 2007
- Deletion of the phosphoinositide 3-kinase p110γ gene attenuates murine atherosclerosisProceedings of the National Academy of Sciences, 2007
- Cyclooxygenase-2 Inhibits UVB-Induced Apoptosis in Mouse Skin by Activating the Prostaglandin E2 Receptors, EP2 and EP4Cancer Research, 2007
- Vascular wall–produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptorsThe Journal of Experimental Medicine, 2007
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001